Slagelse Sygehus
Slagelse, Denmark
6 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Boehringer Ingelheim4,200 enrolled641 locationsNCT06935370
Recruiting
Phase 4
Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
Chronic Obstructive Pulmonary Disease (COPD)
Copenhagen Respiratory Research2,000 enrolled14 locationsNCT06892210
Recruiting
What Influence Re-participation in the Danish Colorectal Screening Program.
PainColonoscopyScreening Colonscopy
Esbjerg Hospital - University Hospital of Southern Denmark8,000 enrolled8 locationsNCT07353632
Recruiting
Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors
Chronic Kidney DiseasesMolecular Sequence VariationAlbuminuria+4 more
Herlev Hospital300 enrolled13 locationsNCT04916132
Recruiting
Phase 4
A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
Heart FailureChronic Kidney DiseasesDiabetes Mellitus, Type 2
Herlev and Gentofte Hospital17,200 enrolled12 locationsNCT06642272